 beneficial effects early dexamethasone administration infants children bacterial meningitis BACKGROUND experimental models meningitis children meningitis dexamethasone meningeal inflammation outcome disease METHODS placebo-controlled double-blind trial dexamethasone therapy infants children National Children Hospital San Jose Costa Rica bacterial meningitis clinical signs meningitis findings characteristic bacterial infection examination cerebrospinal fluid patients dexamethasone cefotaxime cefotaxime placebo Dexamethasone mg kilogram body weight minutes first dose cefotaxime hours days RESULTS demographic clinical laboratory profiles similar patients treatment groups hours beginning therapy mean opening cerebrospinal pressure estimated cerebral perfusion pressure dexamethasone-treated children children cefotaxime controls hours meningeal inflammation concentrations cytokines tumor necrosis factor alpha platelet-activating factor cerebrospinal fluid dexamethasone-treated children whereas controls inflammatory response cerebrospinal fluid hours clinical condition mean prognostic score dexamethasone controls follow-up examination mean months dexamethasone-treated children percent controls percent neurologic audiologic sequelae relative risk sequelae child placebo child dexamethasone percent confidence interval CONCLUSIONS results study dexamethasone administration initiation cefotaxime therapy additional evidence beneficial effect dexamethasone therapy infants children bacterial meningitis